AbbVie’s big Rinvoq ambitions—and the larger JAK class—face even more uncertainty with latest FDA delays aliu Fri, 06/25/2021 – 11:23 More: AbbVie's big Rinvoq ambitions—and the larger JAK class—face even more uncertainty with latest FDA delays Source: fierce
read moreSenti Bio, hot off $645M Spark pact, tees up in-house manufacturing for natural killer cell therapies fkansteiner Fri, 06/25/2021 – 10:14 More: Senti Bio, hot off 5M Spark pact, tees up in-house manufacturing for natural killer cell therapies Source: fierce
read moreBiogen’s $56K Alzheimer’s drug is rounding up bipartisan drug pricing critics in Washington nhigginsdunn Fri, 06/25/2021 – 10:07 More: Biogen's K Alzheimer's drug is rounding up bipartisan drug pricing critics in Washington Source: fierce
read moreMerck taps longtime insider Klobuchar to lead strategy after clinching $9B from Organon split fkansteiner Fri, 06/25/2021 – 09:23 More: Merck taps longtime insider Klobuchar to lead strategy after clinching B from Organon split Source: fierce
read moreStudy of self-reported data found a sizeable portion of individuals reporting persistent COVID-19 symptoms More: Over two million people may have had long COVID in England Source: News
read moreGenetic changes could be used to guide treatment for the rare and aggressive cancer type More: Scientists identify link between genetic changes and rare childhood cancer rhabdomyosarcoma Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals